Bucillamine
Bucillamine
Bucillamine (pronounced boo-sil-a-meen) is a disease-modifying anti-rheumatic drug (DMARD) primarily used in the treatment of rheumatoid arthritis. It is known for its potent immunomodulatory and antioxidant properties.
Etymology
The term "Bucillamine" is derived from its chemical name, N-(mercapto-2-methylpropionyl)-L-cysteine. The drug was first developed in Japan and has been in use since the 1970s.
Pharmacology
Bucillamine works by reducing the activity of the body's immune system, thereby decreasing the inflammation and pain associated with rheumatoid arthritis. It is also known to have antioxidant properties, which help in reducing the damage caused by free radicals in the body.
Related Terms
- Disease-modifying anti-rheumatic drugs (DMARDs): A category of drugs used in the treatment of rheumatoid arthritis that slow down the progression of the disease.
- Rheumatoid arthritis: A chronic inflammatory disorder affecting many joints, including those in the hands and feet.
- Immunomodulatory: Referring to the ability to modify or regulate the immune system.
- Antioxidant: A substance that inhibits oxidation, especially one used to counteract the deterioration of stored food products or remove potentially damaging oxidizing agents in a living organism.
- Free radicals: Atoms or groups of atoms with an odd (unpaired) number of electrons and can be formed when oxygen interacts with certain molecules.
External links
- Medical encyclopedia article on Bucillamine
- Wikipedia's article - Bucillamine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski